Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pequi oil is extracted from the fruits of the pequi tree (Caryocar coriaceum Wittm) and is widely used in traditional medicine in the Brazilian northeast for the management of inflammation and joint pain. A pharmaceutical formulation, PeONC (pequi pulp fixed oil nanoencapsulated with Carbopol® hydrogel), has been developed and evaluated for its therapeutic effect on functionality and pain in women with knee osteoarthritis. This nanoformulation is a gel with a particle size of 209.5 ± 1.06 nm, a pH of 6.23 ± 0.45, a zeta potential of − 23.1 ± 0.4 mV, and a polydispersity index of 0.137 ± 0.52. It consists of spherical nanocapsules with a polymeric wall and an oily nucleus. The gel demonstrated no cytotoxicity and was not irritating to human skin. Treatment with PeONC increased the strength of knee flexor and extensor muscles, improved the total range of motion of the knee, and reduced knee instability, pain, swelling, and locking. It also led to an improvement in functional capacity and social aspects as measured by the SF-36 quality of life questionnaire.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pequi oil.